{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T19:17:16Z","timestamp":1792264636663,"version":"4.4.0"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2026,3,29]],"date-time":"2026-03-29T00:00:00Z","timestamp":1774742400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,3,29]],"date-time":"2026-03-29T00:00:00Z","timestamp":1774742400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Thromb Thrombolysis"],"DOI":"10.1007\/s11239-026-03274-8","type":"journal-article","created":{"date-parts":[[2026,3,29]],"date-time":"2026-03-29T07:09:36Z","timestamp":1774768176000},"page":"897-901","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Indobufen versus aspirin for platelet inhibition: efficacy and safety insights from the INSURE and OPTION trials"],"prefix":"10.1007","volume":"59","author":[{"given":"Chunxing","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhao","family":"Ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,29]]},"reference":[{"issue":"10","key":"3274_CR1","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1016\/S1474-4422(24)00369-7","volume":"23","author":"GBD 2021 Stroke Risk Factor Collaborators","year":"2024","unstructured":"GBD 2021 Stroke Risk Factor Collaborators (2024) Global, regional, and national burden of stroke and its risk factors, 1990-2021: a systematic analysis for the Global Burden of Disease Study 2021. Lancet Neurol 23(10):973\u20131003. https:\/\/doi.org\/10.1016\/S1474-4422(24)00369-7","journal-title":"Lancet Neurol"},{"issue":"3","key":"3274_CR2","doi-asserted-by":"publisher","first-page":"I","DOI":"10.1177\/23969873221100032","volume":"7","author":"J Dawson","year":"2022","unstructured":"Dawson J, B\u00e9jot Y, Christensen LM et al (2022) European stroke organisation (ESO) guideline on pharmacological interventions for long-term secondary prevention after ischaemic stroke or transient ischaemic attack. Eur Stroke J 7(3):I. https:\/\/doi.org\/10.1177\/23969873221100032","journal-title":"Eur Stroke J"},{"issue":"38","key":"3274_CR3","doi-asserted-by":"publisher","first-page":"3720","DOI":"10.1093\/eurheartj\/ehad191","volume":"44","author":"RA Byrne","year":"2023","unstructured":"Byrne RA, Rossello X, Coughlan JJ et al (2023) 2023 ESC guidelines for the management of acute coronary syndromes. Eur Heart J 44(38):3720\u20133826. https:\/\/doi.org\/10.1093\/eurheartj\/ehad191","journal-title":"Eur Heart J"},{"key":"3274_CR4","doi-asserted-by":"publisher","unstructured":"Antithrombotic Trialists' (ATT) Collaboration, Baigent C et al (2009) Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials. Lancet 373(9678):1849-60. https:\/\/doi.org\/10.1016\/S0140-6736(09)60503-1","DOI":"10.1016\/S0140-6736(09)60503-1"},{"issue":"18","key":"3274_CR5","doi-asserted-by":"publisher","first-page":"1894","DOI":"10.1161\/CIRCULATIONAHA.108.191087","volume":"118","author":"DL Bhatt","year":"2008","unstructured":"Bhatt DL, Scheiman J, Abraham NS et al (2008) ACCF\/ACG\/AHA 2008 expert consensus document on reducing the gastrointestinal risks of antiplatelet therapy and NSAID use: a report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents. Circulation 118(18):1894\u2013909. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.108.191087","journal-title":"Circulation"},{"issue":"2 Suppl","key":"3274_CR6","doi-asserted-by":"publisher","first-page":"e89S","DOI":"10.1378\/chest.11-2293","volume":"141","author":"JW Eikelboom","year":"2012","unstructured":"Eikelboom JW, Hirsh J, Spencer FA et al (2012) Antiplatelet drugs: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest 141(2 Suppl):e89S-e119S. https:\/\/doi.org\/10.1378\/chest.11-2293","journal-title":"Chest"},{"issue":"3","key":"3274_CR7","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1093\/ehjcvp\/pvae008","volume":"10","author":"M Galli","year":"2024","unstructured":"Galli M, Occhipinti G, Angiolillo DJ (2024) Aspirin hypersensitivity and intolerance. Eur Heart J Cardiovasc Pharmacother 10(3):173\u2013174. https:\/\/doi.org\/10.1093\/ehjcvp\/pvae008","journal-title":"Eur Heart J Cardiovasc Pharmacother"},{"issue":"1","key":"3274_CR8","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1001\/jama.2016.8662","volume":"316","author":"Y Wang","year":"2016","unstructured":"Wang Y, Zhao X, Lin J et al (2016) Association between CYP2C19 loss-of-function allele status and efficacy of clopidogrel for risk reduction among patients with minor stroke or transient ischemic attack. JAMA 316(1):70\u20138. https:\/\/doi.org\/10.1001\/jama.2016.8662","journal-title":"JAMA"},{"issue":"05","key":"3274_CR9","doi-asserted-by":"publisher","first-page":"240","DOI":"10.3969\/j.issn.1004-8812.2021.05.001","volume":"29","author":"Cardiovascular Physicians Branch of Chinese Medical Doctor Association, Chinese Stroke Association, China Chapter of International Union of Angiology","year":"2021","unstructured":"Cardiovascular Physicians Branch of Chinese Medical Doctor Association, Chinese Stroke Association, China Chapter of International Union of Angiology (2021) Expert consensus on diagnosis and treatment of patients with intolerance and low responsiveness to commonly used oral antiplatelet drugs. Chin J Interv Cardiol 29(05):240\u20139. https:\/\/doi.org\/10.3969\/j.issn.1004-8812.2021.05.001","journal-title":"Chin J Interv Cardiol"},{"issue":"6","key":"3274_CR10","doi-asserted-by":"publisher","first-page":"589","DOI":"10.3760\/cma.j.cn112148-20240325-00168","volume":"52","author":"Chinese Society of Cardiology, Chinese Medical Association, Editorial Board of Chinese Journal of Cardiology","year":"2024","unstructured":"Chinese Society of Cardiology, Chinese Medical Association, Editorial Board of Chinese Journal of Cardiology (2024) Chinese guidelines for the diagnosis and management of patients with chronic coronary syndrome. Chin J Cardiol 52(6):589\u2013614. https:\/\/doi.org\/10.3760\/cma.j.cn112148-20240325-00168","journal-title":"Chin J Cardiol"},{"issue":"7","key":"3274_CR11","doi-asserted-by":"publisher","first-page":"656","DOI":"10.3760\/cma.j.cn112148-20210114-00050","volume":"49","author":"Chinese Society of Cardiology of Chinese Medical Association, Metabolic Cardiovascular Disease Group, Editorial Board of Chinese Journal of Cardiology","year":"2021","unstructured":"Chinese Society of Cardiology of Chinese Medical Association, Metabolic Cardiovascular Disease Group, Editorial Board of Chinese Journal of Cardiology (2021) Chinese expert consensus on comprehensive management of cardiovascular risk in patients with cardiovascular diseases and abnormal glucose metabolism. Chin J Cardiol 49(7):656\u201372. https:\/\/doi.org\/10.3760\/cma.j.cn112148-20210114-00050","journal-title":"Chin J Cardiol"},{"issue":"6","key":"3274_CR12","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1016\/S1474-4422(23)00113-8","volume":"22","author":"Y Pan","year":"2023","unstructured":"Pan Y, Meng X, Yuan B et al (2023) Indobufen versus aspirin in patients with acute ischaemic stroke in China (INSURE): a randomised, double-blind, double-dummy, active control, non-inferiority trial. Lancet Neurol 22(6):485\u2013493. https:\/\/doi.org\/10.1016\/S1474-4422(23)00113-8","journal-title":"Lancet Neurol"},{"issue":"3","key":"3274_CR13","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1161\/CIRCULATIONAHA.122.062762","volume":"147","author":"H Wu","year":"2023","unstructured":"Wu H, Xu L, Zhao X et al (2023) Indobufen or Aspirin on top of Clopidogrel after coronary drug-eluting stent implantation (OPTION): a randomized, open-label, end point-blinded, noninferiority trial. Circulation 147(3):212\u2013222","journal-title":"Circulation"},{"issue":"6","key":"3274_CR14","first-page":"523","volume":"57","author":"The Neurology Branch of the Chinese Medical Association, the Cerebrovascular Disease Group of the Neurology Branch of the Chinese Medical Association","year":"2024","unstructured":"The Neurology Branch of the Chinese Medical Association, the Cerebrovascular Disease Group of the Neurology Branch of the Chinese Medical Association (2024) Chinese guidelines for diagnosis and treatment of acute ischemic stroke 2023. Chin J Neurol 57(6):523\u2013559","journal-title":"Chin J Neurol"},{"issue":"9","key":"3274_CR15","doi-asserted-by":"publisher","first-page":"e9","DOI":"10.1161\/CIR.0000000000001168","volume":"148","author":"SS Virani","year":"2023","unstructured":"Virani SS, Newby LK, Arnold SV et al (2023) 2023 AHA\/ACC\/ACCP\/ASPC\/NLA\/PCNA guideline for the management of patients with chronic coronary disease: a report of the American Heart Association\/American College of Cardiology joint committee on clinical practice guidelines. Circulation 148(9):e9\u2013e119","journal-title":"Circulation"},{"issue":"4","key":"3274_CR16","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1111\/jdi.12785","volume":"9","author":"Y Jing","year":"2018","unstructured":"Jing Y, Hong T, Bi Y et al (2018) Prevalence, treatment patterns and control rates of metabolic syndrome in a Chinese diabetic population: China cardiometabolic registries 3B study. J Diabetes Investig 9(4):789\u2013798","journal-title":"J Diabetes Investig"},{"issue":"9","key":"3274_CR17","doi-asserted-by":"publisher","DOI":"10.1111\/1753-0407.70152","volume":"17","author":"S Wu","year":"2025","unstructured":"Wu S, Xu H, Xu L et al (2025) Indobufen versus Aspirin plus Clopidogrel in patients after coronary stenting in patients with diabetes: a post hoc analysis of the OPTION trial. J Diabetes 17(9):e70152","journal-title":"J Diabetes"},{"issue":"12","key":"3274_CR18","doi-asserted-by":"publisher","first-page":"1586","DOI":"10.5551\/jat.65723","volume":"32","author":"M Wang","year":"2025","unstructured":"Wang M, Pu S, Jin A et al (2025) Effect of stroke severity on efficacy and safety of Indobufen versus Aspirin in patients with moderate to severe stroke: results from the INSURE randomized clinical trial. J Atheroscler Thromb 32(12):1586\u20131600","journal-title":"J Atheroscler Thromb"},{"issue":"15","key":"3274_CR19","doi-asserted-by":"publisher","first-page":"1538","DOI":"10.1016\/j.jacc.2023.07.025.","volume":"82","author":"A Greco","year":"2023","unstructured":"Greco A, Occhipinti G, Giacoppo D et al (2023) Antithrombotic therapy for primary and secondary prevention of ischemic stroke: JACC state-of-the-art review. J Am Coll Cardiol 82(15):1538\u20131557. https:\/\/doi.org\/10.1016\/j.jacc.2023.07.025.","journal-title":"J Am Coll Cardiol"},{"issue":"10","key":"3274_CR20","doi-asserted-by":"publisher","first-page":"1247","DOI":"10.1001\/jama.284.10.1247","volume":"284","author":"FE Silverstein","year":"2000","unstructured":"Silverstein FE, Faich G, Goldstein JL et al (2000) Gastrointestinal toxicity with celecoxib vs nonsteroidal anti-inflammatory drugs for osteoarthritis and rheumatoid arthritis: the CLASS study: a randomized controlled trial. Celecoxib Long-term Arthritis Safety Study. JAMA 284(10):1247\u20131255. https:\/\/doi.org\/10.1001\/jama.284.10.1247","journal-title":"JAMA"},{"issue":"8","key":"3274_CR21","doi-asserted-by":"publisher","first-page":"2135","DOI":"10.3390\/pharmaceutics15082135","volume":"15","author":"J Liu","year":"2023","unstructured":"Liu J, Sun P, Qi X (2023) Reversible and non-competitive inhibition of cyclooxygenase by indobufen for efficient antiplatelet action and relief of gastrointestinal irritation. Pharmaceutics 15(8):2135. https:\/\/doi.org\/10.3390\/pharmaceutics15082135","journal-title":"Pharmaceutics"}],"container-title":["Journal of Thrombosis and Thrombolysis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11239-026-03274-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11239-026-03274-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11239-026-03274-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,13]],"date-time":"2026-06-13T08:32:22Z","timestamp":1781339542000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11239-026-03274-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,29]]},"references-count":21,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2026,4]]}},"alternative-id":["3274"],"URL":"https:\/\/doi.org\/10.1007\/s11239-026-03274-8","relation":{},"ISSN":["1573-742X"],"issn-type":[{"value":"1573-742X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,29]]},"assertion":[{"value":"3 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}